These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18087769)
21. Therapeutic progress in cannabinoid research. Proceedings of a symposium, Groton, Connecticut, October 20-21, 1980. J Clin Pharmacol; 1981; 21(S1):1S-494S. PubMed ID: 6117572 [No Abstract] [Full Text] [Related]
22. Update on fungal infections. Proceedings of the international symposium on fungal infections, February 29-March 1, 2008. Madrid, Spain. Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S79-171. PubMed ID: 19230060 [No Abstract] [Full Text] [Related]
23. Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System. Latorre JG; Schmidt EB Curr Cardiol Rep; 2015 Sep; 17(9):627. PubMed ID: 26238742 [TBL] [Abstract][Full Text] [Related]
24. Proceedings of the Workshop on New Perspectives on Therapeutic Use of Endocannabinoids. Madrid, Spain. October 17-18, 2000. Pharmacol Ther; 2002 Aug; 95(2):101. PubMed ID: 12182957 [No Abstract] [Full Text] [Related]
25. Inhibitors of endocannabinoid degradation: potential therapeutics for neurological disorders. Wendeler M; Kolter T Angew Chem Int Ed Engl; 2003 Jul; 42(26):2938-41. PubMed ID: 12851943 [No Abstract] [Full Text] [Related]
26. 10th International Symposium on Growth and Growth Disorders. Proceedings of a meeting. Madrid, Spain, 19-20 October 1990. Acta Paediatr Scand Suppl; 1991; 372():1-168. PubMed ID: 1927515 [No Abstract] [Full Text] [Related]
27. Proceedings of the 2nd International Meeting of Steroids and Nervous System. February 22-26, 2003, Turin, Italy. Ann N Y Acad Sci; 2003 Dec; 1007():1-406. PubMed ID: 15042715 [No Abstract] [Full Text] [Related]
28. Prevalence of neurological diseases in Madrid, Spain. Cruz Gutierrez-del-Olmo M; Schoenberg BS; Portera-Sanchez A Neuroepidemiology; 1989; 8(1):43-7. PubMed ID: 2643061 [TBL] [Abstract][Full Text] [Related]
29. Proceedings of the 9th International Symposium on New Frontiers of Neurochemistry and Biophysics in the Acute and Chronic Neurological Diseases. Marin, Slovak Republic, 16-19 August 1999. Brain Res Bull; 2000 Nov; 53(4):371-469. PubMed ID: 11221694 [No Abstract] [Full Text] [Related]
30. IBD in different age groups. Proceedings of Falk Symposium 168. March 27-28, 2009. Madrid, Spain. Dig Dis; 2009; 27(3):205-417. PubMed ID: 19953709 [No Abstract] [Full Text] [Related]
31. Integrated molecular medicine for neuronal and neoplastic disorders. Proceedings of the Third International COE Symposium on Elucidation of Pathogenesis and Therapy Development for Neurological and Psychiatric Disorders. December 1-2, 2005. Nagoya, Japan. Ann N Y Acad Sci; 2006 Nov; 1086():1-240. PubMed ID: 17185521 [No Abstract] [Full Text] [Related]
32. [Proceedings of the 7th International Symposium of the Reina SofĂa Institute of Nephrology Research. Madrid, Spain, 16-17 November 2000]. Nefrologia; 2001; 21 Suppl 1():1-69. PubMed ID: 11577682 [No Abstract] [Full Text] [Related]
34. The therapeutic potential of cannabinoids for movement disorders. Kluger B; Triolo P; Jones W; Jankovic J Mov Disord; 2015 Mar; 30(3):313-27. PubMed ID: 25649017 [TBL] [Abstract][Full Text] [Related]
35. Proceedings of the inaugural meeting of the Canadian Consortium for the Investigation of Cannabinoids. Lynch ME; Clark AJ Pain Res Manag; 2001; 6(2):66. PubMed ID: 11854767 [No Abstract] [Full Text] [Related]
36. VI International Symposium on Viral Hepatitis. Proceedings. Madrid, Spain, 3-5 February 1994. J Hepatol; 1995; 22(1 Suppl):1-164. PubMed ID: 7602058 [No Abstract] [Full Text] [Related]
37. Neurodegenerative diseases. Part II: transmissible neurodegenerative disorders. Proceedings of a symposium. Ocho Rios, Jamaica, February 28-March 5, 1993. Mol Neurobiol; 1994; 8(2-3):79-196. PubMed ID: 7999316 [No Abstract] [Full Text] [Related]
38. Special Issue CCA for the proceedings of the 2nd symposium of the Society of CSF analysis and Clinical Neurochemistry. Teunissen C; Parnetti L; Blennow K; Otto M Clin Chim Acta; 2020 Mar; 502():199-200. PubMed ID: 31812757 [No Abstract] [Full Text] [Related]
39. Therapeutic potential of cannabinoid receptor ligands: current status. Singh J; Budhiraja S Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):177-83. PubMed ID: 16810344 [TBL] [Abstract][Full Text] [Related]